Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
2.970
0.00 (0.00%)
Nov 19, 2026, 4:00 PM EST - Market closed
Sionna Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 83.88 | 58.45 | 37.79 | 38.52 | 54.84 |
Short-Term Investments | 140.71 | 177.43 | 109.75 | - | 27.77 |
Cash & Short-Term Investments | 224.59 | 235.88 | 147.54 | 38.52 | 82.61 |
Cash Growth | -9.56% | 59.88% | 283.01% | -53.37% | - |
Prepaid Expenses | 3.94 | 5.54 | 3.46 | 0.69 | 1.22 |
Total Current Assets | 228.53 | 241.42 | 150.99 | 39.21 | 83.83 |
Property, Plant & Equipment | 7.92 | 9.15 | 10.3 | 11.62 | 1.79 |
Long-Term Investments | 25.21 | 74.42 | 20.51 | - | - |
Other Long-Term Assets | 1.6 | 0.96 | 3.96 | 1.12 | 1.74 |
Total Assets | 263.26 | 325.95 | 185.75 | 51.95 | 87.37 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 1.05 | 0.77 | 1.19 | 0.72 | 0.56 |
Accrued Expenses | 13.88 | 9.67 | 7.67 | 6.59 | 7.7 |
Current Portion of Leases | 1.43 | 1.27 | 1.07 | 0.73 | - |
Other Current Liabilities | 0.06 | 0.01 | 0.49 | - | - |
Total Current Liabilities | 16.42 | 11.71 | 10.42 | 8.04 | 8.25 |
Long-Term Leases | 6.32 | 7.41 | 8.68 | 9.75 | - |
Total Liabilities | 22.74 | 19.12 | 19.1 | 17.79 | 8.25 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.05 | 0.05 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 586.64 | 562.6 | 17 | 4.52 | 2.23 |
Retained Earnings | -345.44 | -256.35 | -181.09 | -119.4 | -72.14 |
Comprehensive Income & Other | -0.72 | 0.54 | 0.37 | - | -0.02 |
Total Common Equity | 240.52 | 306.83 | -163.71 | -114.88 | -69.92 |
Shareholders' Equity | 240.52 | 306.83 | 166.66 | 34.16 | 79.12 |
Total Liabilities & Equity | 263.26 | 325.95 | 185.75 | 51.95 | 87.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 7.75 | 8.68 | 9.75 | 10.48 | - |
Net Cash (Debt) | 242.05 | 301.63 | 158.29 | 28.04 | 82.61 |
Net Cash Growth | -23.41% | 90.55% | 464.45% | -66.05% | - |
Net Cash Per Share | 5.38 | 7.55 | 41.02 | 9.56 | 32.05 |
Filing Date Shares Outstanding | 45.24 | 45 | 44.12 | 3.05 | 2.58 |
Total Common Shares Outstanding | 45.21 | 44.72 | 4.72 | 3.05 | 2.58 |
Working Capital | 212.11 | 229.71 | 140.57 | 31.17 | 75.58 |
Book Value Per Share | 5.32 | 6.86 | -34.66 | -37.66 | -27.13 |
Tangible Book Value | 240.52 | 306.83 | -163.71 | -114.88 | -69.92 |
Tangible Book Value Per Share | 5.32 | 6.86 | -34.66 | -37.66 | -27.13 |
Machinery | 2.43 | 2.43 | 2.18 | 2.05 | 0.62 |
Construction In Progress | - | - | - | - | 1.52 |
Leasehold Improvements | 1.92 | 1.92 | 1.85 | 1.85 | - |